Molecular Markers for Colorectal Cancer

被引：28
作者：
Wright, Moriah [1 ]
Beaty, Jenifer S. [2 ,3 ]
Ternent, Charles A. [2 ,3 ]
机构：
[1] Colon & Rectal Surg Inc, 9850 Nicholas St,Suite 100, Omaha, NE 68114 USA
[2] CHI Creighton Univ, Med Ctr Bergan Mercy, Dept Surg, 7500 Mercy Rd, Omaha, NE 68124 USA
[3] Univ Nebraska Med Ctr, Dept Surg, 5 42nd St & Emile St, Omaha, NE 68198 USA
来源：
SURGICAL CLINICS OF NORTH AMERICA | 2017年 / 97卷 / 03期
关键词：
Colorectal neoplasm; Drug therapy; Antineoplastic combined chemotherapy; Biomarkers; Tumor/genetics; Antibodies; Monoclonal/therapeutic use; III COLON-CANCER; THYMIDYLATE SYNTHASE INHIBITION; N-TERMINAL KINASE; CD8; T-CELLS; STAGE-II; 1ST-LINE TREATMENT; GENE-EXPRESSION; PHASE-III; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL;
D O I：
10.1016/j.suc.2017.01.014
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Colorectal cancers develop through at least 3 major pathways, including chromosomal instability, mismatch repair, and methylator phenotype. These pathways can coexist in a single individual and occur in both sporadic and inherited colorectal cancers. In spite of the unique molecular and genetic signatures of colorectal cancers, nonspecific chemotherapy based on the antineoplastic effects of 5-fluorouracil is the cornerstone of therapy for stage III and some stage II disease. Techniques to recognize colorectal cancer at the molecular level have facilitated development of new signature drugs designed to inhibit the unique pathways of colorectal cancer growth and immunity.
引用
收藏
页码：683 / +
页数：20
相关论文
共 119 条
  • [71] Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
    Nishimura, H
    Nose, M
    Hiai, H
    Minato, N
    Honjo, T
    [J]. IMMUNITY, 1999, 11 (02) : 141 - 151
  • [72] Nowak Jonathan A, 2016, Surg Pathol Clin, V9, P427, DOI 10.1016/j.path.2016.04.007
  • [73] RANDOMIZED CONTROLLED TRIAL OF THE EFFECT OF SULINDAC ON DUODENAL AND RECTAL POLYPOSIS AND CELL-PROLIFERATION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
    NUGENT, KP
    FARMER, KCR
    SPIGELMAN, AD
    WILLIAMS, CB
    PHILLIPS, RKS
    [J]. BRITISH JOURNAL OF SURGERY, 1993, 80 (12) : 1618 - 1619
  • [74] Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
    Ogino, Shuji
    Liao, Xiaoyun
    Imamura, Yu
    Yamauchi, Mai
    McCleary, Nadine J.
    Ng, Kimmie
    Niedzwiecki, Donna
    Saltz, Leonard B.
    Mayer, Robert J.
    Whittom, Renaud
    Hantel, Alexander
    Benson, Al B., III
    Mowat, Rex B.
    Spiegelman, Donna
    Goldberg, Richard M.
    Bertagnolli, Monica M.
    Meyerhardt, Jeffrey A.
    Fuchs, Charles S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (23): : 1789 - 1798
  • [75] PD-1 and PD-1 ligands: from discovery to clinical application
    Okazaki, Taku
    Honjo, Tasuku
    [J]. INTERNATIONAL IMMUNOLOGY, 2007, 19 (07) : 813 - 824
  • [76] High frequency of K-ras mutations in human colorectal hyperplastic polyps
    Otori, K
    Oda, Y
    Sugiyama, K
    Hasebe, T
    Mukai, K
    Fujii, T
    Tajiri, H
    Yoshida, S
    Fukushima, S
    Esumi, H
    [J]. GUT, 1997, 40 (05) : 660 - 663
  • [77] The blockade of immune checkpoints in cancer immunotherapy
    Pardoll, Drew M.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (04) : 252 - 264
  • [78] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    Parry, RV
    Chemnitz, JM
    Frauwirth, KA
    Lanfranco, AR
    Braunstein, I
    Kobayashi, SV
    Linsley, PS
    Thompson, CB
    Riley, JL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9543 - 9553
  • [79] Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?
    Perez, Rodrigo O.
    Habr-Gama, Angelita
    Sao Juliao, Guilherme P.
    Vailati, Bruna B.
    Fernandez, Laura M.
    Gama-Rodrigues, Joaquim
    Camargo, Anamaria A.
    [J]. DISEASES OF THE COLON & RECTUM, 2016, 59 (09) : 895 - 897
  • [80] Peters GJ, 1999, CANC DRUG DISC DEV, P101
3456789101112